Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VitalhubVHIBF +0.29%80 EV-to-EBIT is 38.72 as of Jul. 31, 2026. GuruFocus rates VHIBF with a GF Score™ of 80/100 and a GF Value™ of $7.98 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Vitalhub ranks worse than 83.01% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Vitalhub's Enterprise Value for the quarter that ended in Mar. 2026 was $231.18 Mil.
Vitalhub's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitalhub EV-to-EBIT Related Terms
Vitalhub EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Vitalhub's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Vitalhub's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitalhub EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vitalhub's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Vitalhub's EV-to-EBIT falls into.
Vitalhub's current Enterprise Value is $228.66 Mil.
Vitalhub's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitalhub (VHIBF) has a EV-to-EBIT of 38.72 as of Jul. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vitalhub and its competitors. According to the industry distribution chart, Vitalhub ranks #391 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 83%.
Is Vitalhub's EV-to-EBIT too high?
Vitalhub's current EV-to-EBIT is 38.72. The Healthcare Providers & Services industry median EV-to-EBIT is 15.84. Vitalhub's value of 38.72 is 144.4% above this industry median. Based on the distribution chart, Vitalhub ranks #391 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Vitalhub has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitalhub's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitalhub ranks #391 out of 471 companies for EV-to-EBIT. This places Vitalhub in the lower half of its industry. The industry median EV-to-EBIT is 15.84. Vitalhub's value of 38.72 is 144.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitalhub's current EV-to-EBIT of 38.72 is 144.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vitalhub and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitalhub's current EV-to-EBIT is 38.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitalhub stock overvalued right now?
Based on GuruFocus' analysis, Vitalhub (VHIBF) is currently considered Possible Value Trap. The stock's GF Value™ is $7.98, compared to a current price of $4.91 — trading 38.4% below its estimated fair value. The current EV-to-EBIT is 38.72 and 144.4% above the Healthcare Providers & Services industry median of 15.84. Vitalhub's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Vitalhub (VHIBF), the current EV-to-EBIT is 38.72 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitalhub (VHIBF) Overvalued in 2026?
Based on GuruFocus' analysis, Vitalhub stock appears to be undervalued.
The current stock price of $4.91 is trading 38.4% below its estimated GF Value™ of $7.98.
GuruFocus considers Vitalhub to be Possible Value Trap.
Key valuation signals for VHIBF:
EV-to-EBIT: 38.72
GF Value™: $7.98 vs. price of $4.91 (38.4% below fair value)
Industry Position: 144.4% above the Healthcare Providers & Services median (#391 of 471)
No single metric tells the full story. See the VHIBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitalhub Corp provides technology to Health and Human Service providers, including Hospitals, Regional Health Authorities, Mental Health, Long-Term Care, Home Health, and Community and Social Services. Vitalhub solutions span the categories of Electronic Health Records (EHR), Case Management, Care Coordination, Patient Flow, Operational Visibility, and Mobile Apps. It operates in one segment for its operations related to healthcare information systems in the mental health, long-term care, community health service, and hospital sectors. Geographically, it's available in Canada, the United Kingdom, Australia, the USA, Western Asia, and the Rest of the world, and the majority of the revenue comes from the United Kingdom.
80GF Score
Get the complete analysis for VHIBF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VHIBF has been successfully added to your 
